In particular, genes belonging to the BCL2 family appeared particularly relevant in the conditioning outcome of MDS patients; this observation could translate in a possible promising therapeutic approach with BCL2 inhibitors [22]. The gene discussed is BCL2; the disease is myelodysplastic syndrome.